These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21749293)

  • 1. Enhanced transfection rates of small-interfering RNA using dioleylglutamide-based magnetic lipoplexes.
    Lee S; Shim G; Kim S; Kim YB; Kim CW; Byun Y; Oh YK
    Nucleic Acid Ther; 2011 Jun; 21(3):165-72. PubMed ID: 21749293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anionic amino acid-derived cationic lipid for siRNA delivery.
    Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
    J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic liposomal co-delivery of small interfering RNA and a MEK inhibitor for enhanced anticancer efficacy.
    Kang SH; Cho HJ; Shim G; Lee S; Kim SH; Choi HG; Kim CW; Oh YK
    Pharm Res; 2011 Dec; 28(12):3069-78. PubMed ID: 21879387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic nanoparticle and magnetic field assisted siRNA delivery in vitro.
    Mykhaylyk O; Sanchez-Antequera Y; Vlaskou D; Cerda MB; Bokharaei M; Hammerschmid E; Anton M; Plank C
    Methods Mol Biol; 2015; 1218():53-106. PubMed ID: 25319646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient and gentle siRNA delivery by magnetofection.
    Ensenauer R; Hartl D; Vockley J; Roscher AA; Fuchs U
    Biotech Histochem; 2011 Aug; 86(4):226-31. PubMed ID: 20297946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal magnetofection.
    Mykhaylyk O; Sánchez-Antequera Y; Vlaskou D; Hammerschmid E; Anton M; Zelphati O; Plank C
    Methods Mol Biol; 2010; 605():487-525. PubMed ID: 20072903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA.
    Mikhaylova M; Stasinopoulos I; Kato Y; Artemov D; Bhujwalla ZM
    Cancer Gene Ther; 2009 Mar; 16(3):217-26. PubMed ID: 18927599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
    Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
    J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
    Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
    J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of siRNA lipoplexes: Effect of different lipids, in vitro evaluation in cancerous cell lines and in vivo toxicity study.
    Khatri N; Baradia D; Vhora I; Rathi M; Misra A
    AAPS PharmSciTech; 2014 Dec; 15(6):1630-43. PubMed ID: 25145330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA.
    Yu YH; Kim E; Park DE; Shim G; Lee S; Kim YB; Kim CW; Oh YK
    Eur J Pharm Biopharm; 2012 Feb; 80(2):268-73. PubMed ID: 22108492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient and safe delivery of siRNA using anionic lipids: Formulation optimization studies.
    Kapoor M; Burgess DJ
    Int J Pharm; 2012 Aug; 432(1-2):80-90. PubMed ID: 22575754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
    Khurana B; Goyal AK; Budhiraja A; Aora D; Vyas SP
    Drug Deliv; 2013 Feb; 20(2):57-64. PubMed ID: 23537464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in magnetofection and its potential to deliver siRNAs in vitro.
    Mykhaylyk O; Zelphati O; Hammerschmid E; Anton M; Rosenecker J; Plank C
    Methods Mol Biol; 2009; 487():111-46. PubMed ID: 19301645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid delivery of small interfering RNA by biosurfactant MEL-A-containing liposomes.
    Inoh Y; Furuno T; Hirashima N; Kitamoto D; Nakanishi M
    Biochem Biophys Res Commun; 2011 Oct; 414(3):635-40. PubMed ID: 22001930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. siRNA delivery by magnetofection.
    Mykhaylyk O; Zelphati O; Rosenecker J; Plank C
    Curr Opin Mol Ther; 2008 Oct; 10(5):493-505. PubMed ID: 18830925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA.
    Han SE; Kang H; Shim GY; Suh MS; Kim SJ; Kim JS; Oh YK
    Int J Pharm; 2008 Apr; 353(1-2):260-9. PubMed ID: 18178348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
    Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
    J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (B). Efficiency of pharmacological action.
    Dzmitruk V; Szulc A; Shcharbin D; Janaszewska A; Shcharbina N; Lazniewska J; Novopashina D; Buyanova M; Ionov M; Klajnert-Maculewicz B; Gómez-Ramirez R; Mignani S; Majoral JP; Muñoz-Fernández MA; Bryszewska M
    Int J Pharm; 2015 May; 485(1-2):288-94. PubMed ID: 25796120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.